Biyoteknoloji Hisseleri: AI Modelleri for Klinik Deneme Başarı Oranları Tahmini

Biotech stocks experience extreme volatility around clinical trial results.

Trial Design Analysis

Endpoint selection, patient population, comparator arm, and statistical powering all influence trial success probability.

Mechanism-of-Action Scoring

Drug targets with strong genetic validation have higher success rates.

Event-Driven Trading

Binary catalysts create asymmetric risk-reward.